Lapatinib for the treatment of breast cancer in the People’s Republic of China

Hongjiang Wang Department of Breast Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China Abstract: Lapatinib is an oral, small-molecule, reversible inhibitor of both epidermal growth factor receptor and human epidermal growth factor receptor...

Full description

Bibliographic Details
Main Author: Wang HJ
Format: Article
Language:English
Published: Dove Medical Press 2014-07-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/lapatinib-for-the-treatment-of-breast-cancer-in-the-peoplersquos-repub-peer-reviewed-article-OTT